Non-Invasive Prenatal Testing (NIPT) Market to Grow at a Double Digit CAGR until 2025
Increasing interference of
technology in the medical sector has enabled early diagnosis of pre-borne
children which is expected to drive global non-invasive prenatal testing (NIPT)
market
According
to TechSci Research report, “Global Non-invasive
Prenatal Testing (NIPT) Market By Application (Trisomy (Down syndrome,
Edwards syndrome, Patau syndrome), Turner syndrome, Rh Blood type and Others),
By Product (Instruments, Kits and assay), By Technology (Cell free fetal DNA
technology, Massively parallel sequencing, Target Capture Sequences Technology
and others), By End User (Hospitals and diagnostic laboratory), By Region,
Forecast & Opportunities, 2025”, global non-invasive prenatal testing
(NIPT) market is expected to grow at a double-digit CAGR during the next five
years. NIPT is a way to ensure the birth of a healthy child, who is free from
any genetic disorders. This is done by testing small DNA fragments present in
the blood of pregnant women. Additionally, the market is driven by the increase
in gene and chromosome syndrome related cases, growing demand for timely or
early fetal testing across the world and increasing healthcare expenditure. However,
high cost of installation and lack of professionals might hamper the growth of
the market.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "Global
Non-invasive Prenatal Testing (NIPT) Market"
https://www.techsciresearch.com/report/non-invasive-prenatal-testing-nipt-market/4669.html
Global non-invasive prenatal testing (NIPT) market is
segmented on the basis of application, product, technology, end user and region.
The application segment is divided into trisomy, turner syndrome, Rh blood type
and others. The trisomy segment is expected to lead the market in the next five
years as the Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and
Patau syndrome (Trisomy 13) are quite prevalent and cases of genetic and
chromosome disorders are increasing with time, which have contributed to the
dominance of the segment.
In terms of end user, global non-invasive prenatal
testing (NIPT) market can be bifurcated into hospitals and diagnostic
laboratory. Hospitals are the major end users, where the NIPT systems are
deployed, hence they are expected to occupy the dominant market share over the
next five years.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4669
Customers can also request for 10% free customization
on this report.
Leading players in the global non-invasive prenatal testing (NIPT)
market include Roche, Integrated
Genetics, Natera, BGI Genomics, Illumina, Invitae, Genesis Genomics, PerkinElmer,
Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Yourgene
Health, Berry Genomics, Igenomix, Quest Diagnostics, Asper Biogene, Myriad
Genetics, Progenity, Fasteris, Bionet Corp, etc. In order to expand their market share, the companies adopt
various strategies like new product launches, collaborations and many more.
Illumina is one of the leading companies in this market as it keeps on
introducing products related to genotyping, sequencing, gene expression, among
others to the market.
“North America is expected to
dominate the market global non-invasive prenatal testing (NIPT) market during
the next five years due to the early adoption of technologies in the region. Additionally,
major reason for the dominance of this region is the strong financial support,
which enables it to adopt and install new technologies and easily deploy them
in major countries like United States, which reportedly held more than half the
market share in 2019. Moreover, Asia-Pacific is anticipated to be the fastest
growing region in the market on account of the rising awareness among the population
about NIPT in the developing countries.” said Mr. Karan Chechi, Research
Director with TechSci Research, a research based global management consulting
firm.
“Global
Non-invasive Prenatal Testing (NIPT) Market By Application (Trisomy (Down
syndrome, Edwards syndrome, Patau syndrome), Turner syndrome, Rh Blood type and
Others), By Product (Instruments, Kits and assay), By Technology (Cell free
fetal DNA technology, Massively parallel sequencing, Target Capture Sequences
Technology and others), By End User (Hospitals and diagnostic laboratory), By
Region, Forecast & Opportunities, 2025”, has evaluated
the future growth potential of global non-invasive prenatal testing (NIPT)
market and provided statistics & information on market size, shares, structure
and future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global non-invasive prenatal
testing (NIPT) market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]